Tag: PMDA
Renalys Pharma announces first patient dosed in Phase III clinical trial...
Renalys Pharma has announced last week that the first person was dosed in its registrational Phase III clinical trial of sparsentan for the treatment...
Renalys Pharma closes ¥6 billion Series A financing to advance kidney...
Renalys Pharma has recently announced completion of a ¥6 billion Series A financing. The financing was led by Catalys Pacific and SR One, along...